{"id":"W4213038657","doi":"10.1200/jco.2022.40.6_suppl.118","title":"Pembrolizumab (pembro) plus abiraterone acetate (abi) and prednisone (p) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from KEYNOTE-365 cohort D.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Abiraterone acetate; Cohort; Internal medicine; Pembrolizumab; Oncology; Urology; Cancer; Surgery; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001158074,0.0005524268,0.0008018879,0.0002723991,0.0002554181,0.0005998164,0.0005029663,0.0005206455,0.001398065],"category_scores_gemma":[0.0008739629,0.0003402861,0.001154264,0.0004820796,0.0002804398,0.0004428523,0.0003290874,0.0009775469,0.0003704556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054079,"about_ca_system_score_gemma":0.00124698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003727925,"about_ca_topic_score_gemma":0.008699147,"domain_scores_codex":[0.9996284,0.0001508883,0.00003955969,0.00006182746,0.00005807167,0.00006121337],"domain_scores_gemma":[0.999438,0.00007482059,0.0001533092,0.00004368795,0.00003903347,0.0002510354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6681625,0.02221235,0.1074278,0.001400689,0.003832911,0.0003900824,0.0005254564,0.00224523,0.02087045,0.0001251197,0.007405098,0.1654024],"study_design_scores_gemma":[0.2931401,0.3494228,0.3363357,0.000269596,0.004060441,0.0009283812,0.0003393684,0.001709885,0.003829593,0.0001849109,0.009716817,0.00006262423],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937816,0.00307634,0.0001485041,0.000230739,0.00003323529,0.0004927811,0.001374567,0.00002141763,0.0008407656],"genre_scores_gemma":[0.9933671,0.00219208,0.0003845501,0.0004178037,0.00006797283,0.0002801387,0.002475128,0.000007505442,0.0008075585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003727925,"threshold_uncertainty_score":0.007647932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06470924380485907,"score_gpt":0.412626171794028,"score_spread":0.347916927989169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}